Pelthos Therapeutics Inc. (PTHS) Free cash flow 2024–2025
Pelthos Therapeutics Inc. (PTHS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$22.7MFY2025 · since FY2024: -$5.8M → -$22.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.7M | -291.7% |
| FY2024 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTHS financial trends
PTHS RevenuePTHS Net incomePTHS Net marginPTHS Gross profitPTHS Gross marginPTHS Operating incomePTHS Operating marginPTHS Operating cash flowPTHS Capital expendituresPTHS Return on equityPTHS Stock buybacksPTHS Dividends paidPTHS Total assetsPTHS Total liabilitiesPTHS Shareholders’ equityPTHS overview →